Cashing in on science

natoutlookcashUniversity research powers innovation and economic development. Countries with intensive research and development (R&D) programmes differ in their approach to turning lab studies into commercial enterprises.

[Read the story at Nature // May 5, 2016]


Exposure to pharmaceutical contaminants via vegetables

09416-notw7-fruitnvegcxdWith freshwater resources dwindling worldwide, the practice of using treated wastewater to irrigate crops is growing. But that practice might have a downside: In a new study, people who ate vegetables grown using such reclaimed water had increased urine levels of carbamazepine, an antiepileptic drug commonly detected in wastewater.

Continue reading “Exposure to pharmaceutical contaminants via vegetables”

Mutations as munitions: Neoantigen vaccines get a closer look as cancer treatment

nm0216-122-i1In 2010, the Dendreon company received the news it had been hoping for: the US Food and Drug Administration had approved its therapeutic cancer vaccine Provenge for prostate cancer. At the time of Provenge’s approval, the headlines hailed it as groundbreaking, and they noted a surge in the price of Dendreon’s stock as the company announced its $93,000 price tag for the therapy. But enthusiasm fizzled when the company later revealed that fewer people used the therapy than expected, and in November 2014 the company filed for bankruptcy. Continue reading “Mutations as munitions: Neoantigen vaccines get a closer look as cancer treatment”